is part of the Informa Markets Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The pharmaceutical product lifecycle is a complex process with several touchpoints that needs to balance efficient deployment of essential medicines to patients with strict safety compliance, in one of the world’s most heavily regulated sectors.
The global emergency that is COVID-19 has exerted even more pressure on pharmaceutical supply chains, as the industry races not only to develop potential vaccines and therapies for the virus in record time but also to scale up manufacturing to make these treatments available to a global population.
Each year we unite more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities. Global Pharma Insights provides information to aid effective decision making in all the following sectors and more:
• Drug development (pre-clinical and clinical) • API sourcing and procurement • Drug manufacturing and outsourcing • Pharmaceutical packaging and drug delivery • Pharmaceutical distribution • Cell and gene therapies • Cell and gene therapies • Artificial intelligence and machine learning
CPhI Japan interviewed with Satofumi Kawata, Representative Director at Neopharma Japan to talk about how exhibiting at the event has helped them with expanding their business.
CPhI Japan – organised by Informa Markets and UBM Japan – announces that the event will be postponed after an extensive consultation with key stakeholders and consideration of all alternatives.
Planning on joining us at CPhI Japan? Whether you’re a visitor or exhibitor, it’s likely that you’ll have plenty of meetings to attend onsite. Read our important tips regarding Business Etiquette in Japan to be well-prepared for the show.
Japanese culture has a profound impact on decision-making and ultimately business relationships. View our tips and make sure you make the best first impression possible at CPhI Japan.
CPhI Japan sees Japanese R&D reinvigorated with international partnerships proliferating. The show closes as a new wave of innovation is rising across the country, driven by structural and regulatory changes. Read more to discover the latest advancement.
CPhI Japan interviewed Mr. Fujikawa, Chairman at Japan Pharmaceutical Traders' Association about the development and outlook of the Japanese pharma market.
Download our in-depth market report to discover the trends of Japan's pharma market. It also covers increased internationalisation of innovation, with a rise in acquisitions and partnerships with academia.
Japan has the world’s third largest pharma industry. Yet, for many international companies the market has not proved easy to access. Read our in-depth report to understand about the landscape, opportunities and challenges of entering the market.